NanoString Technologies
Latest round
- Series E
Last raised
- Dec 2012
Total raised
- $66M
Investors
- 7
About NanoString Technologies
operates as a healthcare company providing life science tools for research, translational medicine and research applications, and in vitro diagnostics. In May 2024, Bruker Corporation fully acquired NanoString Technologies, Inc. from Patient Square Capital, DFJ, OVP Venture Partners, and many more. NanoString's product portfolio includes three main platforms such as the nCounter analysis system, GeoMx digital spatial profiler, and CosMx spatial molecular imager. The nCounter system offers rapid gene expression insights through 800-plex direct digital detection. The GeoMx DSP enables spatial profiling of transcriptomes and proteins in tissue samples. The CosMx SMI provides high-resolution, multiomic, spatial single-cell imaging, allowing for in-depth cell atlasing and biomarker discovery. In addition, the firm’s platforms support a wide range of research applications in oncology, immunology, neuroscience, and infectious diseases.
Who invested in NanoString Technologies
7 investors across 6 rounds
See all investors in NanoString Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NanoString Technologies
Who invested in NanoString Technologies?
NanoString Technologies has 7 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NanoString Technologies raised?
NanoString Technologies has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did NanoString Technologies last raise money?
NanoString Technologies's most recent round on record is a Series E, in Dec 2012.
What does NanoString Technologies do?
operates as a healthcare company providing life science tools for research, translational medicine and research applications, and in vitro diagnostics.
Where is NanoString Technologies headquartered?
NanoString Technologies is headquartered in Seattle, US.
Which VCs invest in companies like NanoString Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NanoString Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like NanoString Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.